AI assistant
Camlin Fine Sciences Ltd — Share Issue/Capital Change 2021
Mar 2, 2021
59255_rns_2021-03-02_0d0067c6-999f-4e28-a23a-6ca6de689dda.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [100 x 31] intentionally omitted <==
2[nd] March, 2021
||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|
Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)
Dear Sir/Madam,
This is to inform that the Company has allotted 13,750 equity shares of face value of Re.1/‐ each in accordance with the terms of ESOP 2018, on 2[nd] March, 2021.
Consequent to the said allotment the paid up share capital of the Company has gone up to 12,74,98,471 equity shares of face value of Re.1/‐ each aggregating to Rs. 12,74,98,471/‐.
Thanking You,
For Camlin Fine Sciences Limited
==> picture [55 x 52] intentionally omitted <==
==> picture [83 x 34] intentionally omitted <==
Mr. Mandar Godbole GM Legal & Company Secretary (Membership No – 30240)
==> picture [426 x 57] intentionally omitted <==